IT1230752B - Processo per la preparazione di 1,4 diidropiridine polisostituite in forma enantiomericamente pura. - Google Patents

Processo per la preparazione di 1,4 diidropiridine polisostituite in forma enantiomericamente pura.

Info

Publication number
IT1230752B
IT1230752B IT8919477A IT1947789A IT1230752B IT 1230752 B IT1230752 B IT 1230752B IT 8919477 A IT8919477 A IT 8919477A IT 1947789 A IT1947789 A IT 1947789A IT 1230752 B IT1230752 B IT 1230752B
Authority
IT
Italy
Prior art keywords
dihydropyridines
antiomerically
dihydropyridins
poly
substituted
Prior art date
Application number
IT8919477A
Other languages
English (en)
Other versions
IT8919477A0 (it
Inventor
Carmelo A Gandolfi
Marco Frigerio
Carlo Riva
Andrea Zaliani
Giorgio Long
Roberto Di Domenico
Original Assignee
Boehringer Biochemia Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Biochemia Srl filed Critical Boehringer Biochemia Srl
Publication of IT8919477A0 publication Critical patent/IT8919477A0/it
Priority to IT8919477A priority Critical patent/IT1230752B/it
Priority to AU50904/90A priority patent/AU630928B2/en
Priority to US07/743,415 priority patent/US5245039A/en
Priority to PCT/EP1990/000243 priority patent/WO1990009376A1/en
Priority to EP90903015A priority patent/EP0458823B1/en
Priority to DK90903015.7T priority patent/DK0458823T3/da
Priority to HU901962A priority patent/HUT62270A/hu
Priority to CA002047741A priority patent/CA2047741A1/en
Priority to JP2503175A priority patent/JPH04505610A/ja
Priority to AT90903015T priority patent/ATE95813T1/de
Priority to EP90102951A priority patent/EP0383320A1/en
Priority to SU905001680A priority patent/RU2069658C1/ru
Priority to DE90903015T priority patent/DE69003936T2/de
Priority to ES90903015T priority patent/ES2060144T3/es
Priority to KR1019900702275A priority patent/KR0155557B1/ko
Priority to IE58490A priority patent/IE66498B1/en
Priority to NO913188A priority patent/NO177186C/no
Priority to FI913861A priority patent/FI95371C/fi
Application granted granted Critical
Publication of IT1230752B publication Critical patent/IT1230752B/it

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Treatments Of Macromolecular Shaped Articles (AREA)
IT8919477A 1989-02-17 1989-02-17 Processo per la preparazione di 1,4 diidropiridine polisostituite in forma enantiomericamente pura. IT1230752B (it)

Priority Applications (18)

Application Number Priority Date Filing Date Title
IT8919477A IT1230752B (it) 1989-02-17 1989-02-17 Processo per la preparazione di 1,4 diidropiridine polisostituite in forma enantiomericamente pura.
JP2503175A JPH04505610A (ja) 1989-02-17 1990-02-15 エナンチオマー的に純粋なポリ置換された１，４―ジヒドロピリジンの製法
EP90102951A EP0383320A1 (en) 1989-02-17 1990-02-15 A process for preparation of enantiomerically pure polysubstituted 1,4-dihydropyridines
PCT/EP1990/000243 WO1990009376A1 (en) 1989-02-17 1990-02-15 A process for preparation of enantiomerically pure polysubstituted 1,4-dihydropyridines
EP90903015A EP0458823B1 (en) 1989-02-17 1990-02-15 A process for preparation of enantiomerically pure polysubstituted 1,4-dihydropyridines
DK90903015.7T DK0458823T3 (da) 1989-02-17 1990-02-15 Fremgangsmåde til fremstilling af enantiomerisk rene polysubstituerede 1,4-dihydropridiner
HU901962A HUT62270A (en) 1989-02-17 1990-02-15 Process for producing pure enantiomers of polysubstituted 1,4-dihydropyridines and pharmaceutical compositions comprising same
CA002047741A CA2047741A1 (en) 1989-02-17 1990-02-15 Process for preparation of enantiomerically pure polysubstituted 1,4-dihydropyridines
AU50904/90A AU630928B2 (en) 1989-02-17 1990-02-15 A process for preparation of enantiomerically pure polysubstituted 1,4-dihydropyridines
AT90903015T ATE95813T1 (de) 1989-02-17 1990-02-15 Verfahren zur herstellung von enantiomerreinen polysubstituierten 1,4-dihydropyridinen.
US07/743,415 US5245039A (en) 1989-02-17 1990-02-15 Process for preparation of enantiomerically pure polysubstituted 1,4-dihydropyridines
SU905001680A RU2069658C1 (ru) 1989-02-17 1990-02-15 Способ получения энантиомерно чистых 1,4-дигидропиридинов, энантиомерно чистые 1,4-дигидропиридины и изотиоуреиды
DE90903015T DE69003936T2 (de) 1989-02-17 1990-02-15 Verfahren zur herstellung von enantiomerreinen polysubstituierten 1,4-dihydropyridinen.
ES90903015T ES2060144T3 (es) 1989-02-17 1990-02-15 Un procedimiento para la preparacion de 1,4-dihidropiridinas polisustituidas enantiomeramente puras.
KR1019900702275A KR0155557B1 (ko) 1989-02-17 1990-02-15 에난티오머적으로 순수한 다치환 1,4-디히드로피리딘류의 제조 방법
IE58490A IE66498B1 (en) 1989-02-17 1990-02-16 A process for preparation of enantiomerically pure polysubstituted 1,4-dihydropyridines
NO913188A NO177186C (no) 1989-02-17 1991-08-15 Fremgangsmåte ved fremstilling av enantiomert rene polysubstituerte 1,4-dihydropyridiner
FI913861A FI95371C (fi) 1989-02-17 1991-08-15 Menetelmä ja välituotteet enantiomeerisesti puhtaiden polysubstituoitujen 1,4-dihydropyridiinien valmistamiseksi

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT8919477A IT1230752B (it) 1989-02-17 1989-02-17 Processo per la preparazione di 1,4 diidropiridine polisostituite in forma enantiomericamente pura.

Publications (2)

Publication Number Publication Date
IT8919477A0 IT8919477A0 (it) 1989-02-17
IT1230752B true IT1230752B (it) 1991-10-29

Family

ID=11158352

Family Applications (1)

Application Number Title Priority Date Filing Date
IT8919477A IT1230752B (it) 1989-02-17 1989-02-17 Processo per la preparazione di 1,4 diidropiridine polisostituite in forma enantiomericamente pura.

Country Status (17)

Country Link
US (1) US5245039A (it)
EP (2) EP0458823B1 (it)
JP (1) JPH04505610A (it)
KR (1) KR0155557B1 (it)
AT (1) ATE95813T1 (it)
AU (1) AU630928B2 (it)
CA (1) CA2047741A1 (it)
DE (1) DE69003936T2 (it)
DK (1) DK0458823T3 (it)
ES (1) ES2060144T3 (it)
FI (1) FI95371C (it)
HU (1) HUT62270A (it)
IE (1) IE66498B1 (it)
IT (1) IT1230752B (it)
NO (1) NO177186C (it)
RU (1) RU2069658C1 (it)
WO (1) WO1990009376A1 (it)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5571827A (en) * 1990-03-13 1996-11-05 Sepracor Inc. Methods and compositions for treating hypertension, angina and other disorders using optically pure s(-) nitrendipine
US5834496A (en) * 1991-12-02 1998-11-10 Sepracor, Inc. Methods for treating hypertension using optically pure S(-) felodipine
WO1993010781A1 (en) * 1991-12-02 1993-06-10 Sepracor, Inc. Methods and compositions for treating hypertension, angina, and other disorders using optically pure s(-) felodipine
ES2055652B1 (es) * 1992-09-22 1995-03-01 Elmuquimica Farm Sl Procedimiento de obtencion de 2,6-dimetil-4-(2,3-diclorofenil)-1,4-dihidropiridin-3,5-dicarboxilato de 3-etil-5-metil.
ES2055655B1 (es) * 1992-09-22 1995-03-01 Elmuquimica Farm Sl Procedimiento de obtencion de 2,6-dimetil-4-(2-nitrofenil)-1,4-dihidropiridin-3,5-dicarboxilato de 3-isobutil-5-metil.
ES2055654B1 (es) * 1992-09-22 1995-03-01 Elmuquimica Farm Sl Procedimiento de obtencion de 2,6-dimetil-4-(3-nitrofenil)-1,4-dihidropiridin-3,5-dicarboxilato de 3-etil-5-metil.
ES2055653B1 (es) * 1992-09-22 1995-03-01 Elmuquimica Farm Sl Procedimiento de obtencion del 2,6-dimetil-4-(3-nitrofenil)-1,4-dihidropiridin-3,5-dicarboxilato de 3-isopropil-5-(2-metoxi)etil.
GB9405833D0 (en) * 1994-03-24 1994-05-11 Pfizer Ltd Separation of the enantiomers of amlodipine
FR2719585B1 (fr) * 1994-05-05 1996-08-02 Lafon Labor Procédé d'obtention de 1,4-dihydropyridines optiquement pures.
US5554621A (en) * 1995-06-07 1996-09-10 Bristol-Myers Squibb Company Dihydropyridine NPY antagonists: nitrogen heterocyclic derivatives
DE60128683T2 (de) * 2000-04-11 2008-01-24 Sankyo Co., Ltd. Stabilisierte pharmazeutische zusammenstellungen die den calziumkanalblocker azelnidipine enthalten
ITMI20012434A1 (it) 2001-11-20 2003-05-20 Dompe Spa Acidi 2-aril-propionici e composizioni farmaceutiche che li contengono

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3447169A1 (de) * 1984-12-22 1986-07-03 Bayer Ag, 5090 Leverkusen Optisch aktive nitrodihydropyridine, verfahren zur herstellung und ihre verwendung in arzneimitteln
KR930011486B1 (ko) * 1985-08-06 1993-12-08 베링거 만하임 이탈리아 에스.피.에이. 제약상 유효한 2-티오메틸-치환-1,4-디히드로피리딘
EP0225175A3 (en) * 1985-11-28 1988-12-28 FISONS plc Dihydropyridine derivatives, processes for their preparation and pharmaceutical compositions thereof
US4920225A (en) * 1986-12-22 1990-04-24 Laboratoires Syntex S.A. Resolution of 1,4-dihydropyridine derivatives
EP0343193A1 (de) * 1987-03-27 1989-11-29 Byk Gulden Lomberg Chemische Fabrik Gmbh 1,4-dihydropyridine-enantiomere
WO1988007531A1 (fr) * 1987-03-27 1988-10-06 Byk Gulden Lomberg Chemische Fabrik Gmbh Nouveaux composes optiquement actifs

Also Published As

Publication number Publication date
WO1990009376A1 (en) 1990-08-23
ATE95813T1 (de) 1993-10-15
KR0155557B1 (ko) 1998-11-16
EP0458823A1 (en) 1991-12-04
EP0383320A1 (en) 1990-08-22
IE66498B1 (en) 1996-01-10
DE69003936D1 (de) 1993-11-18
AU5090490A (en) 1990-09-05
JPH04505610A (ja) 1992-10-01
NO913188D0 (no) 1991-08-15
CA2047741A1 (en) 1990-08-18
EP0458823B1 (en) 1993-10-13
AU630928B2 (en) 1992-11-12
RU2069658C1 (ru) 1996-11-27
FI913861A0 (fi) 1991-08-15
FI95371C (fi) 1996-01-25
NO913188L (no) 1991-08-15
IE900584L (en) 1990-08-17
DE69003936T2 (de) 1994-03-31
KR910700234A (ko) 1991-03-14
NO177186B (no) 1995-04-24
ES2060144T3 (es) 1994-11-16
IT8919477A0 (it) 1989-02-17
HUT62270A (en) 1993-04-28
NO177186C (no) 1995-08-02
FI95371B (fi) 1995-10-13
US5245039A (en) 1993-09-14
DK0458823T3 (da) 1994-02-21

Similar Documents

Publication Publication Date Title
IT1230752B (it) Processo per la preparazione di 1,4 diidropiridine polisostituite in forma enantiomericamente pura.
BR8705758A (pt) Processo para preparacao de um ester ciclico
IT1217658B (it) Processo perfezionato per la produzione di perfluoropolieteri costituiti sostanzialmente da unita' perfludossietilenche e perfluoroossipropileniche
DE3851070D1 (de) Verfahren zur Herstellung eines Oxid-Verbindungssupraleiterfadens.
IT1109506B (it) Processo enzimatico-microbiologico per la produzione di amminoacidi otticamente attivi a partire da idantoine e/o carbamil-derivati racemi
PT92603A (pt) Processo de producao de factor de crescimento transformante, quimerico,beta
DE3752086D1 (de) Verfahren zur Herstellung von optisch-aktiven Cyclopropancarbonsäure
DE3889398D1 (de) Verfahren zur Herstellung eines Supraleiters.
BR8806375A (pt) Processo para produzir fluoreto de titanio
CA2122254A1 (en) The resolution of racemic verapamil
DE69032341D1 (de) Verfahren zur Herstellung von optisch aktiven Verbindungen mit mehrfachen chiralen Mittelpunkten
DE69231985D1 (de) Verfahren zur Herstellung eines kristallinen Gold-Filmes
ATE118476T1 (de) Verfahren zur herstellung von l-carnitin aus d,l- carnitinnitrilsalzen.
IT1199149B (it) Processo di trattamento successivo per migliorare le proprieta'di solidita'dei coloranti o sbiancanti ottici su di un sub-strato di fibre
IT1183283B (it) Processo per la preparazione di acido - 4 -amino-3-idrossibutirrico otticamente attivo
PT83797B (pt) Processo para a preparacao de compostos carbapenemicos com um substituinte heterotioalquiltio na posicao 2
AT375940B (de) Verfahren zur herstellung neuer 10-halogen-14-oxo-15-hydroxy-e-homoeburnane (3 alpha,17 alpha) sowie deren epimeren, optisch aktiven antipoden und physiologisch vertraeglichen saeureadditionssalze
DE68908843D1 (de) Verfahren zur Herstellung von 4,6-Dimethyl-7-hydroxynonan-3-on.
IT8821301A0 (it) Processo per la preparazione di acidi 1,4-diaril-3-pirazol-acetici
ATE115535T1 (de) Verfahren zur racematspaltung von 2,2- dimethylcyclopropancarbonsäure.
DE3851942D1 (de) Verfahren zur Herstellung von optisch aktiver alpha-Isopropyl-p-chlorophenylessigsäure.
EP0104639A3 (en) Process for improving carbon fibers
PT84807A (pt) Processo para a preparacao de sais e acidos dissolvidos a partir de outros disponiveis mediante resinas de permuta ionica
DE68924482D1 (de) Verfahren zur herstellung optisch aktiver 2-hydroxy-4-phenyl-3-butensäure.
IT1224527B (it) Solfonati di 2,3-epossialchilammonio otticamente attivi, procedimento per la loro produzione, erelativo impiego

Legal Events

Date Code Title Description
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19970227